Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Profit After Tax (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Profit After Tax for 12 consecutive years, with -$7.1 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 9.38% to -$7.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$31.1 million through Dec 2025, down 30.27% year-over-year, with the annual reading at -$27.0 million for FY2025, 18.8% down from the prior year.
  • Profit After Tax hit -$7.1 million in Q4 2025 for vTv Therapeutics, up from -$10.3 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$608000.0 in Q2 2021 to a low of -$11.8 million in Q4 2021.
  • Historically, Profit After Tax has averaged -$5.8 million across 5 years, with a median of -$5.7 million in 2022.
  • Biggest YoY gain for Profit After Tax was 87.82% in 2021; the steepest drop was 1147.51% in 2021.
  • Year by year, Profit After Tax stood at -$11.8 million in 2021, then skyrocketed by 59.77% to -$4.7 million in 2022, then grew by 26.7% to -$3.5 million in 2023, then crashed by 126.48% to -$7.9 million in 2024, then rose by 9.38% to -$7.1 million in 2025.
  • Business Quant data shows Profit After Tax for VTVT at -$7.1 million in Q4 2025, -$10.3 million in Q3 2025, and -$7.4 million in Q2 2025.